Biosimilars Must Play Key Role In EU Pharma Strategy
Medicines For Europe Welcomes Latest Annual Report On Competition
European policy makers must act quickly to harness the benefits of biosimilars as part of the new EU Pharma Strategy, Medicines for Europe insists in the wake of the latest annual report on European biosimilar competition.
